INKT – mink therapeutics, inc. (US:NASDAQ)
Stock Stats
News
MiNK Therapeutics, Inc. (NASDAQ: INKT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
MiNK Therapeutics, Inc. (NASDAQ: INKT) had its price target lowered by analysts at Robert W. Baird from $8.00 to $4.00. They now have an "outperform" rating on the stock.
MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update [Yahoo! Finance]
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
Form 10-Q MiNK Therapeutics, Inc. For: Sep 30
Form 8-K MiNK Therapeutics, Inc. For: Nov 14
Form 8-K MiNK Therapeutics, Inc. For: Oct 30
Form 8-K MiNK Therapeutics, Inc. For: Oct 15
Form 8-K MiNK Therapeutics, Inc. For: Sep 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.